Arrowstreet Capital
NRC icon

Arrowstreet Capital’s NRC Health Common Stock NRC Stock Holding History

Arrowstreet Capital’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$532K Sell
31,305
-17,771
-36% -$302K ﹤0.01% 1660
2025
Q4 		$921K Hold
49,076
– – ﹤0.01% 1571
2025
Q3 		$627K Buy
49,076
+31,599
+181% +$474K ﹤0.01% 1673
2025
Q2 		$294K Buy
+17,477
New +$236K ﹤0.01% 1836

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.24B AUM 31.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Arrowstreet Capital's NRC Position: Q1 2026 in Review

Arrowstreet Capital reduced its NRC Health Common Stock (NRC) stake by 36% in Q1 2026, selling an estimated $302K and leaving 31,305 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

Arrowstreet Capital first reported a position in NRC in Q2 2025 and has held it in 4 quarters since. The position peaked at $921K in Q4 2025. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Arrowstreet Capital held 31,305 shares of NRC Health Common Stock worth $532K as of Q1 2026.
  • Arrowstreet Capital sold 17,771 NRC Health Common Stock shares in Q1 2026, an estimated $302K.
  • NRC Health Common Stock made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1660 holding.
  • Arrowstreet Capital first reported a position in NRC Health Common Stock in Q2 2025 and has held it in 4 quarters since.
  • Arrowstreet Capital's NRC Health Common Stock position peaked at $921K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.